Table:
begin	end	state
1	11	cytoplasmic
12	29	transmembrane
30	38	non-cytoplasmic
39	61	transmembrane
62	83	cytoplasmic
84	110	transmembrane
111	128	non-cytoplasmic
129	148	transmembrane
149	159	cytoplasmic
160	181	transmembrane
182	201	non-cytoplasmic
202	226	transmembrane
227	238	cytoplasmic
239	263	transmembrane
264	292	non-cytoplasmic
293	319	transmembrane
320	330	cytoplasmic
331	351	transmembrane
352	370	non-cytoplasmic
371	388	transmembrane
389	408	cytoplasmic
409	431	transmembrane
432	434	non-cytoplasmic

Input:
>WP_013684424.1 NCBI__GCF_000194625.1:WP_013684424.1
MVREKWSSRIGFLLAGIGSAVGLGNVWRFPYIVGQNGGGAFLIPYLISVFLFGLPLMLLE
FSTGRLFKGSVVSSLKKIRKKFKWIGIAVVSVLTVVLSYYLVITGWILAFFTFTLLGRET
SFESFAQTYFSPLFFVVVTIAASLIVMRGVRKGIEKTSKIMVPALGVLLAVMVIYSLSLP
NAMDGITFYLTPDLSKLSDSSIWAAAFGQAFFSLSVGSGILLTYGSYLEEKISLVNSSML
ITIFDLLVSFMSGLIVFSIASSFGFEVAAGPKLAFSTLPQVFDKVPYGFFLEGIFFLLLF
FAALTSAISMLEIGVAVLIDETSLDRFKSTSLLSSIILVLGFPAALSYSGISLQFTGRPV
LDLMDETFGSFGIPLTALLLSTSISWFLDNLVIAEEINKNAKWKIGKTVVFLTRYFIPIV
LLYVLLTRLHFYLV

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server